Caricamento...
Endocannabinoids and the gastrointestinal tract: what are the key questions?
Cannabinoid (CB(1)) receptor activation acts neuronally, reducing GI motility, diarrhoea, pain, transient lower oesophageal sphincter relaxations (TLESRs) and emesis, and promoting eating. CB(2) receptor activation acts mostly via immune cells to reduce inflammation. What are the key questions which...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group
2007
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2190011/ https://ncbi.nlm.nih.gov/pubmed/17767170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0707422 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|